Fu Jun Li Selected Research

pirfenidone

3/2023

Use of a pulmosphere model to evaluate drug antifibrotic responses in interstitial lung diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fu Jun Li Research Topics

Disease

3	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 01/2017
3	Fibrosis (Cirrhosis) 01/2021 - 01/2017
2	Idiopathic Pulmonary Fibrosis 01/2021 - 01/2017
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2024
1	Lung Diseases (Lung Disease) 03/2023
1	Connective Tissue Diseases (Connective Tissue Disease) 03/2023
1	Bronchiolitis Obliterans 01/2023
1	Disease Progression 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Emphysema 01/2022
1	Burns 01/2021
1	Chemical Burns (Chemical Burn) 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Lung Injury 01/2019
1	Airway Remodeling 01/2017
1	Granuloma 11/2016
1	Infections 11/2016
1	Inflammation (Inflammations) 01/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2009

Drug/Important Bio-Agent (IBA)

4	CadmiumIBA 01/2024 - 01/2017
4	VimentinIBA 01/2021 - 01/2017
2	SmokeIBA 01/2024 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 11/2009
1	Chloride Channels (Chloride Channel)IBA 01/2024
1	pirfenidoneIBA 03/2023
1	Irritants (Vesicants)IBA 01/2023
1	Arsenicals (Arsenic Compounds)IBA 01/2023
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Particulate MatterIBA 01/2021
1	serum P-component (CIt)IBA 01/2021
1	SootIBA 01/2021
1	lewisiteIBA 01/2021
1	withaferin AIBA 01/2019
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019
1	AutoantigensIBA 01/2017
1	Heme Oxygenase-1IBA 11/2016
1	Cadherins (E-Cadherin)IBA 01/2015
1	immunoglobulin M receptorIBA 11/2011

Therapy/Procedure

2	Therapeutics 03/2023 - 01/2021